This information was published on 2026-01-20T00:15:01 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2578722 |
| (220) |
19 Aug 2025
|
| (511) (510) |
Class 5
pharmaceuticals including injectables for treating cancer including breast cancer, pancreatic, and lung cancer; taxanes used in cancer treatment |
| (540) | NABEXEL |
| (550) | Word |
| (730) |
Baxter International Inc.
|
| (750) |
Maxwells Patent & Trade Mark Attorneys Pty Ltd
|
Find out more about publications on the About page.